cyanide gas upon combustion (8) (9) (10) . Fires also release hydrogen cyanide, thus in fire victims, the diagnosis of cyanide intoxication must always be entertained. In studies measuring blood cyanide levels values as high as 1.62~g/ml have been reported (11, 12) . Cigarette smokers also have significant amounts of cyanide in their blood; in this population values up to 0.41~g/ml are documented (13) . In the home, cyanide is found in silver polish and insecticides. KCN powder has been placed in explosive devices to entrap wild animals; their accidental detonation around humans has resulted in lethal exposure (2) .
Iatrogenic exposure to cyanide may result following the use of sodium nitroprusside in hypertensive AAPCC 4 Inhalation or ingestion of cyanide produces dramatic and severe poisoning which can rapidly lead to death. In an adult, as little as 200 mg ingested cyanide or "'" 3 min exposure to hydrocyanic gas may be lethal (1) (2) (3) (4) . Chronic cyanide intoxication may also occur, although this is less likely owing to the high LD 50 of the compound (3) . Hydrocyanic acid and its salts are extraordinarily widespread in nature; they are also available throughout the world as a consequence of their industrial application. Some drugs used therapeutically either contain cyanide or are metabolites of cyanide and as such may potentially result in toxicity.
Natural sources of cyanide include amygdalin and other cyanogenic glycosides. The glycosides are found in apricot and peach pits, as well as in the seeds of apples, pears, plums, and cherries. Bamboo sprouts, cassava and lima beans, almonds and macadamia nuts also contain cyanide, as do hydrangeas, Johnson grass, sorghum, and flax. While human consumption of cyanogenic plants or nuts is common, fatalities are rare (Tab. 1). Death has occurred after the ingestion of large quantities of almonds, apricot pits, or choke cherries (5) (6) (7) . Ingestion of lesser quantities by small children or pets may be fatal.
The industrial sources of cyanide include the electroplating and precious metal extraction industries. The chemical processes involved release hydrogen Death from cyanide toxicity is one of the most rapid and most dramatic seen in the practice of medicine, As with all poisons the proposed therapy has been symptomatic or specifically directed toward the underlying cellular mechanism of action, Both approaches have met with little success owing to the incorrect or delayed diagnosis and the extraordinarily high toxicity of the compound, In this editorial we shall review the nature of cyanide poisoning and the efficacy of the different modalities available for therapy. emergencies or in some instances following the administration of laetrile for the treatment of cancer (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) . Nitroprusside is a ferrocyanide compound which contains 44% cyanide. Cyanide is released when the drug interacts with sulfhydryl groups found in body fluids and tissues. Its toxicity is dose related and recent pharmacokinetic calculations reveal that 3-10 hours of nitroprusside infusion at a dose of5 -10 Ilg/kg/min could cause lethal cyanide intoxication (14) . In clinical practice these infusion rates are never reached, although lesser quantities coupled with longer therapy could lead to toxicity in selected patient groups. While an adult with normal renal function can easily handle~1 Ilg/kg/min for short periods of time, smaller amounts may be lethal in children or in patients with chronic renal failure. The toxin crosses the placenta and its use in the pregnant female may result in fetal demise (18) .
In the 1950's laetrile was touted as the "cure" for cancer, and many patients worldwide received the poison. In the United States, patients often traveled to Mexico to receive the compound. It soon became apparent that toxicity occurred, and a number of deaths consistent with cyanide poisoning resulted. In 1982 Moertal et al (24) reported in a clinical trial that the agent was of no value in cancer therapy, and that its toxicity was due to the cyanide containing ingredient, amygdalin. While deaths from its usage should no longer occur, the agent is likely still administered to Potassium cyanide remains an agent of choice used in suicides and by terrorists. In 1978 several hundred religious zealots died in Jonestown, Guyana as a consequence of ingestion of cyanide-laced fruit juice (25) . We shall probably never know whether the victims knowingly ingested the toxin or whether this, in fact, was mass murder. Airplane fires releasing HCN gas killed 119 passengers in Paris (1973) and 303 pilgrims in Riyadh, Saudi Arabia (1980) (26) . Whether these events were terrorism or accidental is not known. In 1983 the Tylenol® catastrophe, which occurred in the Chicago area, was the result of deliberate tampering of capsules with cyanide after they had been placed in a number of drugstores. Exactly how this was engineered and how many persons were involved is not known. In several of the deaths it appears that the tampered products were ingested accidentally.
Diagnosis and Clinical Features of Cyanide Poisoning
The diagnosis of cyanide poisoning is often difficult without a history of exposure. The odor of "oil of bitter almonds" on the breath of a markedly cyanotic person may be a clue to cyanide exposure. The laboratory tests for whole blood cyanide are very time consuming and are only of value retrospectively. Thus, in cyanide poisoning the physician must have a high index of suspision if any therapy is to be effective.
In general, the signs and symptoms of intoxication correlate with the whole blood cyanide level (Tab. 2) (1-3). The early signs include hyperpnea, agitation, and restlessness, and may be mistaken for anxiety reactions (whole blood CN = 0.5-1.0 Ilg/ml). Headache and palpitations may also be present. As the blood levels increase to 2.5 Ilg/ml, vomiting, hypotension, and bradycardia result. Often these are associated with atrioventricular block and extrasystoles. Coma, cyanosis, convulsions, circulatory collapse, and apnea occur when blood cyanide levels are in the range of 2.5-3.0 Ilg/ml and death usually results at a blood level of 3.0 Ilg/ml. Demyelinating disorders have also been reported after acute exposure, however, these are thought to be nonspecific lesions resulting from profound tissue anoxia (27) .
Chronic exposure to cyanogens causes a number of diverse abnormalities. Optic atrophy, nerve root demyelination, and toxic neuropathy have been reported (28) (29) . In one study more than 50% of workers in a processing factory had thyromegaly and increased 1 131 uptake (10). One hundred per cent of the workers had increased blood hemoglobin concentration as well as increased lymphocyte count (10) . Two of the employees developed psychosis, although it is difficult to know whether this is cause and effect. Abnormal thyroid function has also been found in workers from a photographic plant in which a cyanide extracting process was used to recover silver from X-ray films (10) . Alterations in 8 12 and folate metabolism have also been noted, although the significance of these observations are not known.
Short of having an elevated whole blood cyanide level, the laboratory findings of cyanide poisoning are fairly nonspecific. Perhaps the most valuable clue is the finding of a severe metabolic acidosis with a high anion gap. In clinical medicine there are only seven causes of anion gap metabolic acidosis (Tab. 3) (summarized from Ref 30) . In most of these disorders lactic acidosis is present owing to severe tissue underperfusion and hypoxia. In the patient with cyanide poisoning tissue hypoxia is universally present (see Mechanism of Action below). Laboratory tests ruling out most of the causes of anion gap metabolic acidosis are easily available, and in their absence, the diagnosis of cyanide poisoning should always be entertained. This is particularly true for those populations at high risk: the research scientist or graduate student, the health professional, the industrial worker, and the pediatric patient.
Other findings which may be of some clinical value are an elevated venous oxygen saturation and a decreased arteriovenous O 2 difference (31). These are likely nonspecific findings as are the reports of increased blood hemoglobin concentration (10) . They all probably reflect the severe tissue anoxia associated with cyanide intoxication.
Mechanism of Action
Cyanide is an intracellular toxin, thus plasma or whole blood levels really do not correlate well with the total body burden ( Fig. 1) . Cyanide inhibits the final step of mitochondrial oxidative-phosphorylation by tightly binding to the cytochrome a-a, complex (1, 32, 33) . Cyanide specifically inhibits enzymes that contain the ferric ion (valence of 3 + charges); it has a lesser affinity for the ferrous ion (valence of 2 + charges). In the body the largest store of iron is found in hemoglobin, and this iron is in the ferrous state. When hemoglobin reacts with cyanide, it does so in a reversible fashion forming cyanhemoglobin. However, cyanhemoglobin is formed only in small amounts, and is not a cause of death in cyanide intoxication. Death is due to inhibition of cellular respiration (Le., oxidative-phosphorylation). The respiratory center in the medulla is one of the first parts of the body affected. All tissues depending upon aerobic metabolism are similarly affected.
Therapy of Cyanide Poisoning General Supportive Measures
The immediate therapy of acute cyanide poisoning 350 is symptomatic. Gastric lavage with activated charcoal should be performed to remove any residual cyanide which may be present in the gastrointestinal tract. Intravenous fluids, maintenance of the circulation, intubation and continuous oxygen therapy at high concentration should be instituted. In a case report Graham et al. (34) emphasized the importance of these simple supportive measures. These Authors report patient survival despite the fact that blood cyanide levels, when extrapolated to time zero, were lethal. Oxygen therapy was found to be beneficial in the treatment of acute cyanide intoxication, particularly when combined with other modes of therapy (1, 2) . The mechanism of action for this effect is not clear, but one could postulate that an increase in cell O 2 tension results, somehow reversing inhibition of the mitochondrial a-a3 complex. It is important to note that reversibility has not been documented in vitro, thus, the mechanism must include an additional in vivo factor(s) as well.
Prevents Tissue Cyanide Uptake a) Sodium nitrite (NaN0 2 J and the aminophenols Sodium nitrite (NaN0 2 ) in vitro converts hemoglobin (Fe 2 +) to methemoglobin (Fe 3 + ) (33) ; this reaction presumably occurs in vivo as well. The conversion of hemoglobin to the ferric form should more easily bind cyanide forming cyanmethemoglobin. Consequently, cyanmethemoglobin remains in the extracellular space preventing the extraordinarily rapid cellular uptake of cyanide. Both the nitrites (amyl nitrite, NaN0 2 ) and the aminophenols (4-methylaminophenol, 4-dimethylaminophenol) have been used in cyanide-intoxicated patients (26, 35) . Chung and Wood (36) have shown that the kinetics of methemoglobin formation is too slow to be of value when compared to the kinetics of tissue cyanide uptake. Both the nitrites and the aminophenols cause cardiovascular instability as a result of profound vasodilatation and hypotension (36) . These findings have led some authorities to question their use as an antidote for cyanide intoxication.
If the nitrites or aminophenols are used, methemoglobin levels must be monitored and must be kept below 30% (1, 2) . The usual adult dose of sodium nitrite is 1 ampule (10 ml containing a total of 300 mg) which may be repeated once at 30 min at 150 mg (Le., onehalf the initial dose). The amount of nitrite given must also be titrated with the patient's hemoglobin concentration. For example, a patient having a hemoglobin of 7 gm%, should receive approximately one-third less NaN0 2 than a patient with a hemoglobin of 14 gm%. In children it is critical that the dose be given according to body weight and the hemoglobin concentration. Amyl nitrite perles and intravenous nitrite should not be given simultaneously owing to the subsequent massive formation of methemoglobin. Few physicians are aware of this and few emergency rooms have the information readily available.
b) Hydroxocobalamin
Hydroxocobalamin has also been used as an antidote for a number of years (27, 37, 38) . The agent, when used intravenously, combines with cyanide to form cyanocobalamin (vitamin Bd. To be effective it must be given on a molar basis. The pharmacologic preparation of hydroxocobalamin contains 1 mg/ml, thus 50 parts of the agent must be given to neutralize 1 part of cyanide (38) . Therefore, to completely neutralize 200 mg of cyanide, the approximate lethal dose, 10 liters of hydroxocobalamin solution is required! Of interest, tissue cyanide levels are actually higher following hydroxocobalamin as compared to values seen following the administration of other agents (38) . The reasons for this finding are not clear. In summary, while hydroxocobalamin is not very toxic it is also not particularly effective as compared to other methods used to prevent tissue uptake of cyanide. As noted in Table 1 the drug was administered in "" 160-200 patients in 1985 and 1986 for cyanide exposure all presumably without adverse effect.
c) Dicobalt-EDTA (Ketocyenors)
Dicobalt-EDTA (Kelocyanor®) is a chelating agent which complexes with cyanide forming cobalt cyanide (1, 39) . It is not available in the United States, but has been used in Europe for a number of years. The complex presumably removes cyanide from the circulation, hence reducing its toxicity. Dicobalt-EDTA produces severe hypertension and cardiac arrhythmias when given in the absence of cyanide (1, 39) . Its effi-cacy is questionable at best, and unless cyanide is forced into the extracellular fluid, tissue levels will be minimally affected.
d) Pyruvate
Pyruvate reacts with cyanide to form the nontoxic compound, pyruvic-cyanhydrin (1) . In animals pyruvate administration decreases cyanide toxicity. Whether this approach to therapy significantly alters cyanide toxicity in man is not yet known.
Enhanced Tissue Cyanide Metabolism a) Sodium thiosulfate
Sodium thiosulfate (Na2S203) provides the needed sulfate groups for the mitochondrial enzyme, rhodanase, to convert cyanide to thiocyanate (3, 40, 41) .
Na 2S203 + CN~;
SCN -+ Na 2S03
Thiocyanate is considerably less toxic than cyanide, and is a compound which is cleared by the kidney at a rate of 2.2 ml/min (the renal elimination of cyanide is virtually zero, Figure 1) (42, 43) . Sodium thiosulfate has been used in combination with intravenous nitroprusside to avoid cyanide toxicity in the treatment of severe hypertensive states. Schulz et al. (14) reviewed ten case reports in which the two compounds were used simultaneously. No accumulation of cyanide occurred and the blood pressure lowering efficacy of nitroprusside was fully maintained (14) .
Quantitatively, this approach should be one of the most effective for treating acute cyanide intoxication. The extremely rapid tissue uptake of cyanide combined with its tight binding to the cytochrome-oxidase system should be reversed as quickly as possible. Rhodanase, a naturally occurring mitochondrial enzyme, mediates the transfer of sulfur from thiosulfate to the cyanide ion (3, 33) . The rhodanase enzyme is present in large amounts, but the reaction is limited by the endogenous supply of thiosulfate (3). Chung and Wood (36) have demonstrated a chemical equilibrium between thiocyanate and cyanide in blood. Native hemoglobin acts as a peroxidase in this equilibrium. At an acid pH methemoglobin is a more effective peroxidase than is oxyhemoglobin (36) . Both methemoglobinemia and acidosis are present in the plasma of cyanide intoxicated patients, suggesting that if substrate were made available for the enzyme, the toxicity of cyanide should be less. In 49 cases of cyanide intoxication, Chen et al. (40) report successful therapy of 48 patients so treated with thiosulfate and nitrite. Such combination therapy should force the intracellular conversion of cyanide to thiocyanate and renal elimination of the less toxic of the two compounds (Le., thiocyanate) would result.
b) Hyperbaric oxygen
Theoretically, hyperbaric oxygen should increase tissue O 2 tension and increase the elimination of cyanide from the mitochondria. Experimentally this approach has proven very controversial (44) (45) (46) (47) . Perhaps the most dramatic report of its efficacy is that in five smoke inhalation victims (13) . It should be noted, however, that these patients concomitantly received amyl nitrite perles, sodium thiosulfate, and sodium nitrite. In these patients whole blood cyanide levels decreased from 1.62 I!g/ml to 0.15 I!g/ml and four of the five victims survived (13) . The mechanism for this effect is not at all clear. In carefully controlled animal studies we and others have shown that urine oxygen tension, an index of renal tissue oxygen metabolism, is markedly increased after the administration of agents proven to cause renal cell death (48) . We interpret this to mean the renal cells are not extracting O 2 for metabolism, even though sufficient oxygen is available. Conversely, in the isolated working turtle heart, 10-3 KCN perfusion results in low perfusate O 2 tension; this tissue is capable of extracting oxygen and is able to convert glucose into glycogen even in the presence of cyanide (49) . These findings suggest that tissues may vary in their sensitivity to cyanide, although carefully controlled studies in mammlian tissues have not yet been performed.
While the mechanism of action for the efficacy of hyperbaric oxygen is unknown, its use seems appropriate in selected instances. In infants and young children it should not be used as the well known effects on the lung (pulmonary dysplasia) and retinal tissue (retrolental fibroplasia) have been documented (50) (51) (52) (53) . In the absence of a hyperbaric chamber high O 2 gas should be administered by mask or nasal can-352 nula. In all likelihood this latter approach is as effective; it certainly is more practical.
c) Hemodialysis
We have recently reported the effectiveness of hemodialysis in cyanide poisoning (54) . At first glance, this appears to be an unlikely mode of therapy for cyanide toxicity for two reasons: first, the lethal effects of cyanide are related to its intracellular action on metabolism; second, the renal clearance of cyanide is virtually zero. Cyanide is a small molecule, however, and as such should be easily dialyzable. When a constant infusion of KCN was given to anephric animals an increase in the lethal dose resulted when hemodialysis was used concomitantly. The hemodialysis clearance of cyanide was found to be "" 40 ml/min and the extraction ratio was 0.43 (54) . We reasoned that as an intracellular toxin, maneuvers forcing cyanide from inside the cell into the extracellular fluid should be even more effective in preventing mortality. Thiosulfate is known to cause the metabolism of cyanide to thiocyanate by stimulating the enzyme, rhodanase (3, 33) . When animals were given a constant infusion of KCN plus sodium thiosulfate, and hemodialysis was then performed, the dose of cyanide tolerated increased two-fold compared to hemodialysis alone. We postulated the mechanism for these observations was as follows ( Fig. 1) : the dialysis clearance for cyanide in the extracellular fluid is approximately 40 ml/min. When thiosulfate is given, the rhodanase enzyme is stimulated forming the intramitochondrial conversion of the cytochrome oxidase-bound cyanide to thiocyanate. Thiocyanate then diffuses into the extracellular fluid where it is rapidly cleared by dialysis. The hemodialysis clearance of thiocyanate exceeds 200 ml/min (42) . This high clearance coupled with its renal clearance (2.2 ml/min) allows a greater cyanide burden to be tolerated.
"Antidote Kit"
In 1970, the Eli Lilly Company manufactured an "antidote kit" for cyanide poisoning. The kit costs approximately $100 and contains amyl nitrite perles, 10 ml sodium nitrite (30 mg/ml), and 50 ml sodium thiosul-fate (250 mg/ml). The chemicals in the kit are found on virtually every laboratory shelf, however, as they are not patentable individually, the components in the Lilly kit are the only sources available for human use. Specific instructions are provided for the intravenous administration of sodium nitrite and sodium thiosulfate according to age, body weight, and blood hemoglobin. Instructions for the use of amyl nitrite perles are also given.
Review of data presented by the American Association of Poison Control Centers from 1983 to 1986 reveals that the number of deaths from cyanide is very low and virtually stable, varying from 3 to 10 per year. Use of the antidote kit has increased (2, 55, 56) as have the number of cyanide exposures. In 1983 the kit was used 27 times while the number of deaths known to occur from cyanide was 3 (of 105 chemical exposures and 608 plant exposures). In the very next year the kit was administered 102 times while the number of deaths known to occur was 5 (of 232 chemical exposures and 2216 plant exposures). In 1986 the kit was administered 84 times and the number of deaths was 10 (of 512 chemical exposures and 2924 plant exposures) (see Table 1 ). From the available data one cannot tell whether all of the compounds in the kit were used, or whether only part of the antidote was administered. While manufacture of the kit is certainly not profitable for the pharmaceutical company, its use should be tempered by a critical analysis of the newer scientific information. Injudicious administration of any .. Kit" .without attention to newer modes of therapy is like using the extract of the foxglove in the 1990's to treat congestive heart failure in the USA. While of some efficacy, the approach is very dangerous!
Summary
Considering the difficulties following the administration of nitrites (or aminophenols) or cobalt-EDTA as well as the ineffectivenes of hydroxycobalamin and pyruvate, we feel that a more sensible treatment for acute cyanide intoxication is hemodialysis combined with the intravenous administration of sodium thiosulfate. The addition of hemodialysis to such a regimen is helpful in three ways. First, it removes the small extracellular reservoir of cyanide, particularly if the poi-son is still being absorbed from the gastrointestinal tract. Second, it corrects the severe lactic acidosis seen in virtually all cases of cyanide toxicity. As with most poisons death from metabolic acidosis alone is likely. Third, the removal of thiocyanate, the end product of cyanide metabolism, results in a maneuver which should decrease both tissue and plasma cyanide levels.
The immediate treatment of acute cyanide intoxication is supportive, as it is with most all drugs and poisons. Gastric lavage using activated charcoal should be initiated immediately to remove any remaining cyanide in the gastrointestinal tract. Simultaneously, high flow oxygen should be administered either by nasal cannula or by endotracheal intubation. Correction of the metabolic acidosis should be instituted with bicarbonate. Immediate hemodialysis should be performed with the concomitant administration of thiosulfate. Animal studies suggest that continuous infusion of thiosulfate (12 mg/kg/hr) is more effective for treating cyanide intoxication than is bolus administration (41, 51) . Bolus administration is the currently recommended form of thiosulfate therapy in humans. The Lilly kit contains a 50 ml ampule of thiosulfate having 12.5 gm, which in adults may be repeated once at one-half the dose. Based upon our data, coupled with the results of adding hemodialysis, continuous infusion of thiocyanate is preferable in the treatment of acute cyanide intoxication. The infusion of one ampule of thiosulfate (12.5 gm) may be given during a four hour hemodialysis treatment. This amount still allows for the administration of the one-half additional dose.
In conclusion, hemodialysis combined with thiosulfate administration is an effective adjunct to the treatment of acute cyanide intoxication. Supportive therapy is mandatory. More importantly, the attending physician must have a high index of suspicion that cyanide intoxication may be present as any delay is virtually always fatal.
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